BLU News and Press, BELLUS Health Inc. From 03/19/21

NEW YORK, March 19, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against BELLUS Health Inc. (“BELLUS”) (NASDAQ: BLU) in the United States District Court for the Southern District of New York on behalf of those who ...

The 2020 global pandemic hurt many businesses across various industries. Many companies operating in travel and tourism-related, arts and entertainment , restaurant, and accommodation sectors suffered the most. Some of the operations might not return to pre-corona levels and eventually ...

BELLUS Health (BLU): FY GAAP EPS of -$0.54 misses by $0.01.Revenue of $15kCash, cash equivalents and short-term investments of $98.3M.Press Release For further details see: BELLUS Health EPS misses by $0.01

- Initiated the Phase 2b SOOTHE clinical trial in refractory chronic cough; topline results expected Q4 2021 with an interim analysis expected in mid-2021 - - Initiated the Phase 2 BLUEPRINT clinical trial in chronic pruritus associated with atopic dermatitis; topline results ...

Today, the stock market is back in a bull mode as the Dow, S&P, and Nasdaq are all pointing toward a higher morning session. Of course, after a bit of a drought over the last few days, traders are now seeking opportunities, and penny stocks could be one area of focus. Something to keep ...

Analysts Are Bullish On These Penny Stocks What do you look for when it comes to finding the best penny stocks to buy ? Are you looking for technical set-ups, or are you searching for news catalysts? You may even be looking to find cheap stocks for your watch list. Another way trade...

Are You Following Analysts On These Penny Stocks? This year has gotten off to a strong start already. That goes for penny stocks & blue-chips alike. Many stocks are reaching new 52-week and all-time highs. Meanwhile, the broader markets have weathered the economic storm well. Bu...

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough and other hypersensitization-related disorders, today announced...

Gainers: [[HTOOW]] +18.7%. [[SIF]] +16.4%. [[GBS]] +11.9%. [[ODT]] +10.9%. [[LAZRW]] +10.2%.Losers: [[ALT]] -10.5%. [[BFIIW]] -5.8%. [[BLU]] -4.2%. [[SCPL]] -4.0%. [[CATB]] -3.4%. For further details see: HTOOW, SIF, ALT and CATB among after-hours movers

BELLUS Health (BLU) announces at-the-market distribution with Jefferies, pursuant to which the company may from time to time sell common shares of an aggregate offer price of up to $50M. Stock down 1.20% AH.Previously, Dec. 14: Dosing underway in BELLUS Health's mid-stage atopi...